Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 08, 2016 09:44 ET | Source: Chembio Diagnostics, Inc.

Chembio Diagnostics Reports 2015 Financial Results

MEDFORD, N.Y., March 08, 2016 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (“POC”) diagnostic tests for infectious diseases, today reported financial...
March 07, 2016 08:50 ET | Source: Chembio Diagnostics, Inc.

Chembio to Collaborate With Bio-Manguinhos/Fiocruz to Develop Point-of-Care Zika Diagnostic Tests for Brazil

MEDFORD, N.Y., March 07, 2016 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced plans to...
February 29, 2016 08:50 ET | Source: Chembio Diagnostics, Inc.

Chembio to Host Conference Call to Discuss 2015 Financial Results

MEDFORD, N.Y., Feb. 29, 2016 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (NASDAQ:CEMI), which develops, manufactures, markets and licenses point-of-care diagnostic tests, announced today that...
February 19, 2016 08:50 ET | Source: Chembio Diagnostics, Inc.

Chembio Awarded Grant From Paul G. Allen Family Foundation to Develop Point-of-Care Diagnostic Tests for Zika Virus and Related Febrile Illnesses

MEDFORD, N.Y., Feb. 19, 2016 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, has been awarded a grant from...
January 26, 2016 08:50 ET | Source: Chembio Diagnostics, Inc.

Chembio to Sell Its SURE CHECK® HIV 1/2 Assay in the United States Beginning June 1, 2016

MEDFORD, N.Y., Jan. 26, 2016 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, will begin selling its SURE...
November 12, 2015 08:50 ET | Source: Chembio Diagnostics, Inc.

Chembio Diagnostics Reports Third Quarter Financial Results

MEDFORD, N.Y., Nov. 12, 2015 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (“POC”) diagnostic tests for infectious diseases, today reported financial...
November 03, 2015 08:50 ET | Source: Chembio Diagnostics, Inc.

Chembio to Commercialize Family of DPP® Malaria Assays

MEDFORD, N.Y., Nov. 03, 2015 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced plans to...
November 02, 2015 08:50 ET | Source: Chembio Diagnostics, Inc.

Chembio to Host Conference Call to Discuss Third Quarter 2015 Financial Results

MEDFORD, N.Y., Nov. 02, 2015 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (NASDAQ:CEMI), which develops, manufactures, markets and licenses point-of-care diagnostic tests, announced today that...
October 21, 2015 08:50 ET | Source: Chembio Diagnostics, Inc.

Chembio Expands Point-of-Care Platform and Launches the DPP(R) Micro Reader

MEDFORD, N.Y., Oct. 21, 2015 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, announced today that it has...
October 07, 2015 10:05 ET | Source: Chembio Diagnostics, Inc.

Chembio Awarded Grant From the Paul G. Allen Ebola Program to Develop a Multiplex Point-of-Care Test for Febrile Illnesses

MEDFORD, N.Y., Oct. 07, 2015 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, has been awarded a grant from...